Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01076387 · ClinicalTrials.gov registry record · Phase 3

Randomized Trial Comparing Robotic and Open Radical Cystectomy

A Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
Phase 3
Development phase
124
Enrollment target

NCT01076387: Completed Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT01076387 is a Phase 3 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 124 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01076387, a Phase 3 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
Phase 3
Development phase
124 participants
Enrollment target

Study Summary

The purpose of this study is to determine if using robotic surgical technology during bladder cancer surgery helps to reduce complications during and after the surgery. The removal of the bladder and lymph nodes will be done by a robotic or by an open technique. It may be a Robotic-assisted Radical Cystectomy (RARC) and Pelvic Lymph Node Dissection. Or it may be an Open Radical Cystectomy (ORC) and Pelvic Lymph Node Dissection.

Interventions

  • PROCEDURE open radical cystectomy
  • PROCEDURE robotic-assisted radical cystectomy

Trial Details

FieldValue
Enrollment Target 124 participants
Start Date 2010-02
Est. Completion 2020-03-12
Phase Phase 3

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT01076387

The ClinicalTrials.gov registry entry for NCT01076387 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which open radical cystectomy is the first listed.

NCT01076387 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01076387 about?

NCT01076387 is a clinical study titled "Randomized Trial Comparing Robotic and Open Radical Cystectomy". The purpose of this study is to determine if using robotic surgical technology during bladder cancer surgery helps to reduce complications during and after the surgery. The removal of the bladder and lymph nodes will be done by a robotic or by an open technique. It may be a Robotic-assisted Radical ...

What is the current status of trial NCT01076387?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 124 participants. The study started on 2010-02. Estimated completion is 2020-03-12.

What interventions are being tested in trial NCT01076387?

The interventions under investigation include: open radical cystectomy (PROCEDURE), robotic-assisted radical cystectomy (PROCEDURE).

Who is sponsoring clinical trial NCT01076387?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.